MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
270.24
+2.87
+1.07%
After Hours: 271.00 +0.76 +0.28% 19:59 08/21 EDT
OPEN
267.83
PREV CLOSE
267.37
HIGH
272.66
LOW
267.00
VOLUME
6.19M
TURNOVER
--
52 WEEK HIGH
276.47
52 WEEK LOW
170.35
MARKET CAP
651.25B
P/E (TTM)
31.34
1D
5D
1M
3M
1Y
5Y
1D
Johnson & Johnson Stock Shines on Dividends and Lung Cancer Bet
TipRanks · 17h ago
Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken
TipRanks · 19h ago
If a Stock Market Crash Is Coming, History Says Buying and Holding These Stocks Is a Smart Move
The Motley Fool · 20h ago
3 Dividend Stocks to Buy and Hold for the Next 5 Years
NASDAQ · 23h ago
Dividend Champion, Contender, And Challenger Highlights: Week August 23
Seeking Alpha · 1d ago
Markets at Midday: Rally Accelerates with Dow Up Nearly 500 Points
TipRanks · 1d ago
Lawmakers ask FDA to scrutinize Chinese trials amid deaths - report
Seeking Alpha · 1d ago
Merck vs. J&J: Which Healthcare Giant Should Investors Choose?
NASDAQ · 1d ago
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. Its segments include Innovative Medicine and MedTech. The Innovative Medicine segment focuses on various therapeutic areas, oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases and cardiovascular and metabolism. Its products include CARVYKTI (ciltacabtagene autoleucel), DARZALEX (daratumumab), DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), ERLEADA (apalutamide), among others. The MedTech segment develops and manufactures a broad portfolio of products used in cardiovascular, orthopedics, surgery, and vision supporting physicians, hospitals, eye care professionals and healthcare systems across a range of acute and elective procedures. The Cardiovascular portfolio includes electrophysiology products. It is also focused on proprietary Firelink degrader antibody conjugate platform.

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.